COVID-19 and diabetes management: What should be considered?

Ceriello, Antonio; Stoian, Anca Pantea; Rizzo, Manfredi

Ceriello, Antonio; Stoian, Anca Pantea; Rizzo, Manfredi.

Ceriello A; IRCCS MultiMedica, Milan, Italy. Electronic address: antonio.ceriello@hotmail.it.
Stoian AP; Diabetes, Nutrition and Metabolic Diseases Department, "Carol Davila" University of Medicine, Bucharest, Romania.
Rizzo M; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of South Carolina, Columbia, SC, USA; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Italy.

Diabetes Res Clin Pract ; 163: 108151, 2020 05.

Article in English | MEDLINE | ID: covidwho-72309

Keywords

COVID-19; Cardiovascular disease; DPP4; Diabetes; GLP-1RA; Hydroxychloroquine; Pioglitazone; SGLT-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Diabetes Res Clin Pract Journal subject: Endocrinology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google